Ronald Ennis, MD
Radiation Oncology · New York, NYNPI 1780668400
Payments from drug & device makers
Across 10 payments — averaging $244.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$2K
- Mevion_medical_systems_inc$93
- Elekta, Inc.$75
- Bioprotect Medical, Inc.$33
- Novartis$19
- Varian Medical Systems, Inc.$17
What the payments were for
- Speaking & faculty fees$1,68069%
- Travel & lodging$53122%
- Food & beverage$23710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 3 | $2,211 |
| Mevion_medical_systems_inc | 2 | $93 |
| Elekta, Inc. | 1 | $75 |
| Bioprotect Medical, Inc. | 2 | $33 |
| Novartis | 1 | $19 |
| Varian Medical Systems, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Varian Treatment$466
How this compares
$2,449 in reported general payments places this provider in the 75th percentile of 397 radiation oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 13 | $42,402 |
| MyrbetriqMirabegron | 47 | $29,629 |
| Tamsulosin Hcl | 108 | $2,069 |
| Trospium Chloride | 19 | $977 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $202 |
| Oxybutynin Chloride | 13 | $155 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in New York
- Narek ShaverdianNew York$9.8M
- Timothy ChanNew York$3.8M
- Brandon ImberNew York$2.8M
- Silvia FormentiNew York$2.7M
- Christopher BarkerNew York$2.5M
- Michael ZelefskyNew York$1.5M
- Eileen ConnollyNew York$1.1M
- Jonathan YangNew York$946K
- Nancy LeeNew York$914K
- Benjamin CooperNew York$800K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.